Clinical and Experimental Hepatology
| Abbreviation | ceh |
| Journal Impact | 1.46 |
| Quartiles(Global) | GASTROENTEROLOGY & HEPATOLOGY(Q3) |
| ISSN | 2392-1099, 2449-8238 |
| h-index | 20 |
Clinical and Experimental Hepatology is a quarterly journal published by the Polish Association for the Study of Liver. It aims to provide scientific and educational content. This peer-reviewed journal publishes original and review articles that describe the latest advancements in clinical and basic research in the field of hepatology.
| Publication Information | Publisher: Termedia Publishing House Ltd.，Publishing cycle: ，Journal Type: journal，Open Access Journals: No |
| Basic data | Year of publication: 2015，Proportion of original research papers: 88.10%，Self Citation Rate:6.70%， Gold OA Rate: 2.08% |
Journal Citation Format
Those examples are references to articles in scholarly journals and how they are supposed to appear in your bibliography.
Not all journals organize their published articles in volumes and issues, so these fields are optional. Some electronic journals do not provide a page range, but instead list an article identifier. In a case like this it's safe to use the article identifier instead of the page range.
A journal article with 1 author
A journal article with 2 authors
A journal article with 3 authors
A journal article with 5 or more authors
Books Citation Format
Here are examples of references for authored and edited books.
Thesis Citation Format
Web sites Citation Format
Sometimes references to web sites should appear directly in the text rather than in the bibliography.
Patent Citation Format
Staying up late manually editing references? ivySCI automatically matches journals and helps you generate references with a single click.
Click the button below to start a free trial!
Role of aspartate aminotransferase to platelet ratioin prediction of intrahepatic cholestasis of pregnancy
2024-1-1
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
2024-1-1
Cannabinoids and the endocannabinoid system in liver diseases
2024-1-1
Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgery
2024-1-1
Telemedicine in the tertiary liver unit: A feasibility study
2024-1-1
Role of aspartate aminotransferase to platelet ratioin prediction of intrahepatic cholestasis of pregnancy
2024-1-1
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
2024-1-1
Cannabinoids and the endocannabinoid system in liver diseases
2024-1-1
Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgery
2024-1-1
Telemedicine in the tertiary liver unit: A feasibility study
2024-1-1